Cargando…

Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study

BACKGROUND: Oral lipid-lowering treatment (LLT) is the standard of care for patients with cardiovascular disease (CVD). However, insufficient treatment intensity and poor adherence can lead to suboptimal treatment benefit, rendering patients at increased risk of CVD. AIMS: The objective of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Svensson, Maria K., Sorio Vilela, Francesc, Leósdóttir, Margrét, Banefelt, Jonas, Lindh, Maria, Dun, Alexander Rieem, Norhammar, Anna, Villa, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Academia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171571/
https://www.ncbi.nlm.nih.gov/pubmed/35722183
http://dx.doi.org/10.48101/ujms.v127.8296
_version_ 1784721696163364864
author Svensson, Maria K.
Sorio Vilela, Francesc
Leósdóttir, Margrét
Banefelt, Jonas
Lindh, Maria
Dun, Alexander Rieem
Norhammar, Anna
Villa, Guillermo
author_facet Svensson, Maria K.
Sorio Vilela, Francesc
Leósdóttir, Margrét
Banefelt, Jonas
Lindh, Maria
Dun, Alexander Rieem
Norhammar, Anna
Villa, Guillermo
author_sort Svensson, Maria K.
collection PubMed
description BACKGROUND: Oral lipid-lowering treatment (LLT) is the standard of care for patients with cardiovascular disease (CVD). However, insufficient treatment intensity and poor adherence can lead to suboptimal treatment benefit, rendering patients at increased risk of CVD. AIMS: The objective of this study was to evaluate trends in LLT intensity and adherence in Sweden over time, and their association with major adverse cardiovascular events (MACE) after recent myocardial infarction (MI), and also to assess the impact of transition from secondary to primary care on intensity and adherence. METHODS AND RESULTS: This retrospective observational cohort study used data from Swedish nationwide patient registers and included patients on LLT after an MI in the years 2010–2016 (n = 50,298; mean age, 68 years; 69% men). LLT intensity was evaluated over time (overall, for 2010–2013 and for 2014–2016) as the proportion of patients prescribed low-, moderate-, and high-intensity LLT. Adherence was assessed as the proportion of days covered. A combined measure of intensity and adherence was also considered. Differences in treatment patterns and MACE were assessed. Initiation of high-intensity LLT increased over the two time periods studied (2010–2013, 32%; 2014–2016, 91%). Adherence varied by LLT intensity and was highest in patients receiving high-intensity LLT (>80%), especially during the first time period. Little change in treatment intensity or the combined measure of intensity and adherence was observed after transition to primary care. There was a significant association between the combined measure of intensity and adherence and MACE reduction (hazard ratio [95% confidence interval] per 10% increase in the combined measure: 0.84 [0.82–0.86]; P < 0.01). CONCLUSION: The proportion of post-MI patients with high LLT intensity and adherence has increased in recent years, with little change after transfer from specialist to primary care. The combination of LLT intensity and adherence is important for preventing future cardiovascular events.
format Online
Article
Text
id pubmed-9171571
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Open Academia
record_format MEDLINE/PubMed
spelling pubmed-91715712022-06-17 Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study Svensson, Maria K. Sorio Vilela, Francesc Leósdóttir, Margrét Banefelt, Jonas Lindh, Maria Dun, Alexander Rieem Norhammar, Anna Villa, Guillermo Ups J Med Sci Original Article BACKGROUND: Oral lipid-lowering treatment (LLT) is the standard of care for patients with cardiovascular disease (CVD). However, insufficient treatment intensity and poor adherence can lead to suboptimal treatment benefit, rendering patients at increased risk of CVD. AIMS: The objective of this study was to evaluate trends in LLT intensity and adherence in Sweden over time, and their association with major adverse cardiovascular events (MACE) after recent myocardial infarction (MI), and also to assess the impact of transition from secondary to primary care on intensity and adherence. METHODS AND RESULTS: This retrospective observational cohort study used data from Swedish nationwide patient registers and included patients on LLT after an MI in the years 2010–2016 (n = 50,298; mean age, 68 years; 69% men). LLT intensity was evaluated over time (overall, for 2010–2013 and for 2014–2016) as the proportion of patients prescribed low-, moderate-, and high-intensity LLT. Adherence was assessed as the proportion of days covered. A combined measure of intensity and adherence was also considered. Differences in treatment patterns and MACE were assessed. Initiation of high-intensity LLT increased over the two time periods studied (2010–2013, 32%; 2014–2016, 91%). Adherence varied by LLT intensity and was highest in patients receiving high-intensity LLT (>80%), especially during the first time period. Little change in treatment intensity or the combined measure of intensity and adherence was observed after transition to primary care. There was a significant association between the combined measure of intensity and adherence and MACE reduction (hazard ratio [95% confidence interval] per 10% increase in the combined measure: 0.84 [0.82–0.86]; P < 0.01). CONCLUSION: The proportion of post-MI patients with high LLT intensity and adherence has increased in recent years, with little change after transfer from specialist to primary care. The combination of LLT intensity and adherence is important for preventing future cardiovascular events. Open Academia 2022-05-04 /pmc/articles/PMC9171571/ /pubmed/35722183 http://dx.doi.org/10.48101/ujms.v127.8296 Text en © 2022 The Author(s). Published by Upsala Medical Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Svensson, Maria K.
Sorio Vilela, Francesc
Leósdóttir, Margrét
Banefelt, Jonas
Lindh, Maria
Dun, Alexander Rieem
Norhammar, Anna
Villa, Guillermo
Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
title Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
title_full Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
title_fullStr Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
title_full_unstemmed Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
title_short Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
title_sort effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a swedish register-based study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171571/
https://www.ncbi.nlm.nih.gov/pubmed/35722183
http://dx.doi.org/10.48101/ujms.v127.8296
work_keys_str_mv AT svenssonmariak effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy
AT soriovilelafrancesc effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy
AT leosdottirmargret effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy
AT banefeltjonas effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy
AT lindhmaria effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy
AT dunalexanderrieem effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy
AT norhammaranna effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy
AT villaguillermo effectsoflipidloweringtreatmentintensityandadherenceoncardiovascularoutcomesinpatientswitharecentmyocardialinfarctionaswedishregisterbasedstudy